Related Experiment Videos
Improving our knowledge in PD-L1 testing in lung cancer: the archival sample is 'promoted'!
1Thoracic Medical Oncology, Istituto Nazionale Tumori, "Fondazione G. Pascale" - IRCCS, Napoli, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Fetal treatment of sacrococcygeal teratoma: state of the art.
Frontiers in pediatrics·2025
Corrigendum: Gut and spleen anomalies associated with DYRK1A syndrome.
Frontiers in pediatrics·2024
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Clinical evaluation of novel deep learning-based auto-segmentation software: Utility and potential pitfalls.
Journal of applied clinical medical physics·2026
HisToSpatialCNV: an interpretable deep learning method predicting spatial copy number variations from histopathology images.
Nature biomedical engineering·2026
The reliability-clarity paradox in vascular digital health: A nurse-led evaluation of ChatGPT-4's accuracy in diabetic foot ulcer management.
Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing·2026